CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +10,000 | $67.85 | $679K | 36,316.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −1,300 | $625.25 | $813K | 35,016.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −1,100 | $626.47 | $689K | 33,916.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −1,326 | $627.41 | $832K | 32,590.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −2,356 | $628.19 | $1.5M | 30,234.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −2,094 | $629.63 | $1.3M | 28,140.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −971 | $630.39 | $612K | 27,169.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −743 | $631.39 | $469K | 26,426.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Sale | −110 | $632.19 | $70K | 26,316.64 |
| 2021-11-08 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −10,000 | 35,535 | ||
| 2021-10-29 | JUNIUS DANIEL M Director | Grant or award | +10 | $666.14 | $7K | 2,906 |
| 2021-10-29 | ESSIG STUART Director | Grant or award | +36 | $666.14 | $24K | 1,100 |
| 2021-10-29 | COLLINS Asha Director | Grant or award | +30 | $666.14 | $20K | 137 |
| 2021-10-11 | Claflin Bruce L. Director | Exercise or conversion | +1,921 | $160.28 | $308K | 1,921 |
| 2021-10-11 | Claflin Bruce L. Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −1,921 | 0 | ||
| 2021-09-01 | Smith Martin Alexander Executive Vice President | Grant or award · Non-Qualified Stock Option (right-to-buy) | +124 | 124 | ||
| 2021-09-01 | Smith Martin Alexander Executive Vice President | Grant or award · Incentive Stock Option (right-to-buy) | +588 | 588 | ||
| 2021-09-01 | Smith Martin Alexander Executive Vice President | Grant or award · Restricted Stock Unit | +74 | 74 | ||
| 2021-08-31 | Turner Kathy V Senior Vice President | Exercise or conversion | +1,256 | $79.54 | $100K | 4,131.39 |
| 2021-08-31 | Turner Kathy V Senior Vice President | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,256 | 0 |
Page 64 of 74 · 1,474 trades